Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

These drugs inhibit interleukin (IL)-5, while Dupixent inhibits IL-4 and IL-13, but can be considered a rival because it is also an injection. Patients may opt to take the others because of their ...

Novartis has axed development of its mid-stage eczema drug ZPL389 ... towards an important FDA approval for its Dupixent (dupilumab) injection for the skin disease also known as atopic dermatitis.

Medical experts and death row inmates file legal briefs challenging legality of Arizona's execution drugs ahead of March ...

Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts overall ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

Researchers at Rutgers Health have discovered that a weekly injection of the diabetes drug tirzepatide may offer a less painful and more accessible alternative to current treatments for congenital ...

Without changes in lifestyles then as soon as the drug injection stops the weight gain will start again. Without changes in the nature of the food that is on offer to us every time we go to the ...

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...